#CRISPR

Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.

A third of mice treated with gene editing technique plus long-acting antiretrovirals showed no remaining traces of HIV.

This finding may eventually make HIV gene therapies more affordable and accessible.

The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.

In a recent small trial, researchers have been unable to detect viable virus in the tissues of two monkeys that received the treatment.

Chinese scientist claims to have edited embryos to make children HIV resistant.

A pair of twin girls have been born as a part of his efforts, greatly alarming the worldwide research community.

Scientists have discovered a swifter and more precise way to edit the genome of immune cells, opening doors for cancer and HIV therapies.

Scientists have discovered a swifter and more precise way to edit the genome of immune cells, opening doors for cancer and HIV therapies.

Gilead Sciences’ second round of cure grants supports these five research projects.

This Ohio researcher will be using CRISPR gene editing to target HIV, thanks to funding from The Campbell Foundation.

For the first time, scientists have used the powerful, cutting-edge CRISPR/Cas9 gene-editing method to snip HIV out of infected mice.

The feat marks an important milestone in the mammoth effort to find a cure for HIV.

An amfAR grant goes to two University of Massachusetts scientists exploring a novel technique.

Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.

Because these targets are human genes, therapies that go after them would be less susceptible to drug resistance.